| scholarly article | Q13442814 |
| P50 | author | Robert Weissert | Q42326415 |
| Hans Wigzell | Q6240885 | ||
| P2093 | author name string | Hans Lassmann | |
| Tomas Olsson | |||
| Maria K Storch | |||
| Katrien L de Graaf | |||
| Judit Wefer | |||
| Sana Eltayeb | |||
| Anna Lobell | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| bias | Q742736 | ||
| oligodendrocyte | Q916698 | ||
| P304 | page(s) | 1806-1813 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response | |
| P478 | volume | 170 |
| Q37773270 | Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies |
| Q37559970 | Emerging immunopharmacological targets in multiple sclerosis |
| Q43290322 | FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis |
| Q35122159 | Gene therapy in autoimmune, demyelinating disease of the central nervous system |
| Q37387234 | Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells |
| Q36577275 | Immunopathogenesis and immunotherapy of multiple sclerosis |
| Q30853672 | Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis |
| Q48824018 | Inverse vaccination, the opposite of Jenner's concept, for therapy of autoimmunity |
| Q37313911 | Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary |
| Q33211930 | Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule. |
| Q35949884 | Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase |
| Q37347220 | Proteomic strategies in multiple sclerosis and its animal models |
| Q42487727 | Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF. |
| Q54572757 | The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGbeta by DNA immunization. |
| Q34875345 | Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment |
| Q36985173 | Toward the development of rational therapies in multiple sclerosis: what is on the horizon? |
| Q45877509 | Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance. |
| Q34482931 | Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment |
| Q28591514 | Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis |
| Q37085898 | Vaccines for multiple sclerosis: progress to date |
Search more.